tradingkey.logo

ReShape Lifesciences Inc

RSLS
3.920USD
0.000
Market hours ETQuotes delayed by 15 min
10.29MMarket Cap
LossP/E TTM

ReShape Lifesciences Inc

3.920
0.000

More Details of ReShape Lifesciences Inc Company

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

ReShape Lifesciences Inc Info

Ticker SymbolRSLS
Company nameReShape Lifesciences Inc
IPO dateOct 06, 2016
CEOMr. Paul F. Hickey
Number of employees17
Security typeOrdinary Share
Fiscal year-endOct 06
Address1001 Calle Amanecer
CitySAN CLEMENTE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code92673
Phone19494296680
Websitehttps://www.reshapelifesciences.com/obalon/
Ticker SymbolRSLS
IPO dateOct 06, 2016
CEOMr. Paul F. Hickey

Company Executives of ReShape Lifesciences Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+14.29%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Mohanjit Jolly
Mr. Mohanjit Jolly
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+14.29%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--

Revenue Breakdown

Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
No Data
By RegionUSD
Name
Revenue
Proportion
United States
931.00K
83.65%
Europe
98.00K
8.81%
Australia
78.00K
7.01%
Rest of World
6.00K
0.54%
By Business
By Region
No Data

Shareholding Stats

Updated: Sat, Oct 18
Updated: Sat, Oct 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Iron Pillar Fund I Ltd
8.27%
HUNTER VENTURES LIMITED
7.45%
Lee (Felix Kar Chung)
7.13%
Lam (Man Kwon)
7.13%
Lee (Jacob Chin Hin)
7.13%
Other
62.89%
Shareholders
Shareholders
Proportion
Iron Pillar Fund I Ltd
8.27%
HUNTER VENTURES LIMITED
7.45%
Lee (Felix Kar Chung)
7.13%
Lam (Man Kwon)
7.13%
Lee (Jacob Chin Hin)
7.13%
Other
62.89%
Shareholder Types
Shareholders
Proportion
Individual Investor
27.53%
Corporation
15.80%
Investment Advisor
0.09%
Hedge Fund
0.06%
Other
56.52%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
29
8.09K
0.15%
+4.85K
2025Q2
34
270.50K
11.34%
+257.74K
2025Q1
42
35.95K
1.85%
+23.58K
2024Q4
36
92.62K
3.05%
+33.67K
2024Q3
40
51.79K
41.95%
-7.67K
2024Q2
37
52.29K
38.14%
-3.61K
2024Q1
40
50.20K
37.62%
-6.41K
2023Q4
40
53.11K
38.38%
+43.81K
2023Q3
41
10.13K
39.05%
+5.49K
2023Q2
42
5.11K
36.27%
+1.18K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BMO Nesbitt Burns Inc.
2.50K
0.05%
+2.50K
--
Jun 30, 2025
UBS Financial Services, Inc.
2.14K
0.04%
+1.59K
+284.92%
Jun 30, 2025
Leonite Fund I LP
2.00K
0.04%
+2.00K
--
Feb 18, 2025
FirstFire Global Opportunities Fund LLC
2.00K
0.04%
+2.00K
--
Feb 18, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Date
Type
Ratio
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Jun 15, 2021
Merger
3→1
Jun 15, 2021
Merger
3→1
View more
KeyAI